Please use this identifier to cite or link to this item:
|Title:||Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries|
|Authors:||Miguela A. Caniza|
Scott C. Howard
St. Jude Children's Research Hospital
Neonatology Intensive Care Unit
University of Tennessee Health Science Center
Hospital for Sick Children University of Toronto
University of Memphis
Azienda Ospedaliera San Gerardo Monza
|Citation:||Expert Review of Hematology. Vol.8, No.5 (2015), 627-645|
|Abstract:||© 2015 © Informa UK, Ltd. Infections are the most important cause of morbidity and mortality in children treated for acute lymphoblastic leukemia (ALL). The rates of infection-Associated mortality are up to 10-Times higher in low-and middle-income countries (LMIC) than in high-income countries. The prevention, early recognition and management of infectious complications is especially challenging in LMIC because of disease and poverty-related factors, as well as the shortage of trained personnel, supplies, diagnostic tools and adequate organizational infrastructure. Children in LMIC with ALL, who are frequently underweight, are at increased risk of community-Acquired pathogens, nosocomial multidrug-resistant pathogens and opportunistic microorganisms. This review summarizes the challenges of managing the major categories of infections in children receiving treatment for ALL and provides updated practical recommendations for preventing and managing these infections in LMIC.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.